This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Induction Therapy Does Not Improve Survival for Clinical Stage T2N0 Esophageal Cancer

Monday, July 28, 2014

Submitted by


Source Name: Journal of Thoracic Oncology


Speicher, Paul J.; Ganapathi, Asvin M.; Englum, Brian R.; Hartwig, Matthew G.; Onaitis, Mark W.; D’Amico, Thomas A.; Berry, Mark F.

The efficacy of induction therapy for clinical T2 esophageal cancer was evaluated using the National Cancer Database.  Pretreatment staging was accurate in only 27% of pts.  42% of pts were upstaged and 32% were downstaged.  Induction therapy had no survival benefit.   

Add comment

Log in or register to post comments